{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:25:38Z","timestamp":1785536738223,"version":"3.56.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>African horse sickness (AHS) is a serious viral disease of equids resulting in the deaths of many equids in sub-Saharan Africa that has been recognized for centuries. This has significant economic impact on the horse industry, despite the good husbandry practices. Currently, prevention and control of the disease is based on administration of live attenuated vaccines and control of the arthropod vectors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 29 horses in 2 groups, were vaccinated. Eighteen horses in Group 1 were further divided into 9 subgroups of 2 horses each, were individually immunised with one of 1 to 9 AHS serotypes, respectively. The eleven horses of Group 2 were immunised with all 9 serotypes simultaneously with 2 different vaccinations containing 5 serotypes (1, 4, 7\u20139) and 4 serotypes (2, 3, 5, 6) respectively. The duration of this study was 12\u2009months. Blood samples were periodically withdrawn for serum antibody tests using ELISA and VNT and for 2\u2009weeks after each vaccination for PCR and virus isolation. After the booster vaccination, these 27 horses seroconverted, however 2 horses responded poorly as measured by ELISA. In Group 1 ELISA and VN antibodies declined between 5 to 7\u2009months post vaccination (pv). Twelve months later, the antibody levels in most of the horses decreased to the seronegative range until the annual booster where all horses again seroconverted strongly. In Group 2, ELISA antibodies were positive after the first booster and VN antibodies started to appear for some serotypes after primary vaccination. After booster vaccination, VN antibodies increased in a different pattern for each serotype. Antibodies remained high for 12\u2009months and increased strongly after the annual booster in 78% of the horses. PCR and virus isolation results remained negative.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Horses vaccinated with single serotypes need a booster after 6\u2009months and simultaneously immunised horses after 12\u2009months. Due to the non-availability of a facility in the UAE, no challenge infection could be carried out.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12917-020-02540-y","type":"journal-article","created":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T11:03:51Z","timestamp":1598958231000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Immune response of horses to inactivated African horse sickness vaccines"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6020-6719","authenticated-orcid":false,"given":"Marina","family":"Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunitha","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Pfeffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rekha","family":"Raghavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Wernery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,1]]},"reference":[{"key":"2540_CR1","unstructured":"Coetzer J, Guthrie AJ. African horse sickness. In: Infectious diseases of livestock, ed. Coetzer J, Tustin RC. 2nd, volume 2. Cape Town: Oxford University Press; 2014. p. 1231-46."},{"key":"2540_CR2","unstructured":"Zientara St. (2010). African horse sickness. In: Infectious and parasitic diseases of livestock, ed. P.-Ch. Lef\u00e8vre, J. Blancou, R. Chermette, G. Uilenberg, volume 1, Lavoisier, pp. 689-704."},{"key":"2540_CR3","unstructured":"Fern\u00e1ndez PJ, White WR. African horse sickness. In: Fern\u00e1ndez PJ, White WR, editors. Atlas of Transboundary Animal Diseases. Paris: OIE; 2010. p. 11\u20138."},{"key":"2540_CR4","unstructured":"Guthrie AJ, Quan M. African horse sickness. In: Mair TS, Hutchinson RE, editors. Infectious diseases of the horse: A peer-reviewed publication; 2009. p. 72\u201382."},{"key":"2540_CR5","unstructured":"Merck Veterinary Manual (2016). Merck and Co., INC., Kenilworth, Bluetongue, pp. 738\u2013741."},{"key":"2540_CR6","unstructured":"Salama S.A., EL Husseini M.M. and Abdalla S.K. (1979 And 1980). 3rd and 4th Ann. Rep. US AHS Project 169, Cairo: 55-69, 91\u201398."},{"key":"2540_CR7","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1136\/vr.101083","volume":"172","author":"ND Diouf","year":"2012","unstructured":"Diouf ND, Etter E, Lo MM, Lo M, Akakpo AJ. Outbreaks of African horse sickness in Senegal and methods of control of the 2007 epidemic. Vet Rec. 2012;172:152.","journal-title":"Vet Rec"},{"key":"2540_CR8","unstructured":"OIE. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. African Horse Sickness. 8th ed. Paris: OIE; 2018. p. 1237\u201352."},{"issue":"1","key":"2540_CR9","doi-asserted-by":"publisher","first-page":"139","DOI":"10.20506\/rst.34.1.2350","volume":"34","author":"M Van Vuuren","year":"2015","unstructured":"Van Vuuren M, Penzhorn BL. Geographic range of vector-borne infections and their vectors: the role of African wildlife. Rev Sci Tech Off Int Epiz. 2015;34(1):139\u201349.","journal-title":"Rev Sci Tech Off Int Epiz"},{"issue":"2","key":"2540_CR10","doi-asserted-by":"publisher","first-page":"353","DOI":"10.20506\/rst.34.2.2362","volume":"34","author":"H Attoui","year":"2015","unstructured":"Attoui H, Mohd JF. Zoonotic and emerging orbivirus infections. Rev Sci Tech Off Int Epiz. 2015;34(2):353\u201361.","journal-title":"Rev Sci Tech Off Int Epiz"},{"issue":"2","key":"2540_CR11","doi-asserted-by":"publisher","first-page":"315","DOI":"10.20506\/rst.34.2.2359","volume":"34","author":"S Zientara","year":"2015","unstructured":"Zientara S, Weyer CT, Lecollinet S. African horse sickness. Rev Sci Tech Off Int Epiz. 2015;34(2):315\u201327.","journal-title":"Rev Sci Tech Off Int Epiz"},{"key":"2540_CR12","doi-asserted-by":"crossref","unstructured":"Oura C. A possible role for domestic dogs in the spread of African horse sickness virus. Vet Rec. 2018;182:713\u20134. Research Comment..","DOI":"10.1136\/vr.k2641"},{"key":"2540_CR13","doi-asserted-by":"crossref","unstructured":"O'Dell N, Arnot L, Janisch CE, Steyl JC. Clinical presentation and pathology of suspected vector transmitted African horse sickness in south African domestic dogs from 2006 to 2017. Vet Rec. 2018;182:715. original research.","DOI":"10.1136\/vr.104611"},{"issue":"12","key":"2540_CR14","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.3201\/eid2212.160718","volume":"22","author":"CT Weyer","year":"2016","unstructured":"Weyer CT, Grewar JD, Burger P, Rossouw E, Lourens C, Joone C, le Grange M, Coetzee P, Venter E, Martin DP, MacLachlan NJ, Guthrie AJ. African horse sickness caused by genome reassortment and reversion to virulence of live, attenuated vaccine viruses, South Africa, 2004\u20132014. Emerg Infect Dis. 2016;22(12):2087\u201396.","journal-title":"Emerg Infect Dis"},{"key":"2540_CR15","doi-asserted-by":"crossref","unstructured":"Susan J. Dennis, Ann E. Meyers, Inga I, Hitzeroth and Edward P. Rybicki (2019). African horse sickness: a review of current understanding and vaccine development. Pp. 11-16.","DOI":"10.3390\/v11090844"},{"key":"2540_CR16","unstructured":"Otieno OGE, Amimo JO. Molecular epidemiology of African horse sickness in Kenya. Afr Horse Sickness Conf Proc. Abstract, Nairobi Kenya. 2018:33\u20134."},{"key":"2540_CR17","volume-title":"African horse sickness outbreak investigation and disease surveillance using molecular techniques. Doctoral thesis","author":"CT Weyer","year":"2016","unstructured":"Weyer CT. African horse sickness outbreak investigation and disease surveillance using molecular techniques. Doctoral thesis. South Africa: University Pretoria; 2016."},{"key":"2540_CR18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jviromet.2012.12.014","volume":"189","author":"AJ Guthrie","year":"2013","unstructured":"Guthrie AJ, MacLachlan NJ, Jone C, Lourens CW, Weyer CT, Quan M, Monyai MS, Gardner IA. Diagnostic accuracy of a duplex real-time reverse transcription quantitative PCR assay for detection of African horse sickness virus. J Virol Methods. 2013;189:30\u20135.","journal-title":"J Virol Methods"},{"key":"2540_CR19","unstructured":"Goosen D. 2019;32(29):3611-6. info@ahsequilink.co.za."},{"key":"2540_CR20","unstructured":"Serological response of foals to polyvalent and monovalent live attenuated African horse sickness virus vaccines. J. E. Crafford1*, C.W. Lourens2, T.K. Smit3, I. A. Gardner4, N. J. MacLachlan1,5, A. J. Guthrie2."},{"key":"2540_CR21","unstructured":"European Medicines Agency (2009). mail@emea.europa.euhttps:\/\/www.ema.europa.eu\/en."},{"key":"2540_CR22","unstructured":"Lef\u00e8vre P. -Ch., Mellor Ph. and Saegerman Cl. (2010) Bluetongue. In: Infectious and Parasitic Diseases of Livestock, ed. P.-Ch. Lef\u00e8vre, Blancou J., Chermette R., Uilenberg G., Volume 1, Lavoisier, pp. 663\u2013688."},{"key":"2540_CR23","first-page":"891","volume-title":"Bluetongue, African horse sickness and related Orbivirus: Proc. of the sec. Int. symposium","author":"J House","year":"1992","unstructured":"House J, Lombard M, Dubourget P, House C, Mebus C. Efficacy of an inactivated African horse sickness serotype 4 vaccine. In: Walton TE, Osburn BI, editors. Bluetongue, African horse sickness and related Orbivirus: Proc. of the sec. Int. symposium. Boca Raton: CRC Press; 1992. p. 891\u20135."},{"key":"2540_CR24","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1136\/vr.132.17.440","volume":"132","author":"FG Davies","year":"1993","unstructured":"Davies FG, Soi RK, Binepal VS. African horse sickness viruses isolated in Kenya. Vet Rec. 1993;132:440.","journal-title":"Vet Rec"},{"key":"2540_CR25","first-page":"261","volume-title":"Equine infectious diseases","author":"AA van Dijk","year":"1999","unstructured":"van Dijk AA. African horse sickness vaccine development. In: Wernery U, Wade JF, Mumford JA, Kaaden O, editors. Equine infectious diseases. 8th ed. Newmarket: R, R and W Publications; 1999. p. 261\u20135.","edition":"8"},{"key":"2540_CR26","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1017\/S0950268800048512","volume":"106","author":"C Hamblin","year":"1991","unstructured":"Hamblin C, Mellor PS, Graham SD, Hooghuis H, Montejano RC, Cubillo MA, Boned J. Antibodies in horses, mules and donkeys following monovalent vaccination against African horse sickness. Epidemiol Infect. 1991;106:365\u201371.","journal-title":"Epidemiol Infect"},{"key":"2540_CR27","first-page":"26","volume":"10","author":"J Lubroth","year":"1988","unstructured":"Lubroth J. African horse sickness and the epizootic in Spain in 1987. Equine Pract. 1988;10:26\u201333.","journal-title":"Equine Pract"},{"key":"2540_CR28","doi-asserted-by":"publisher","unstructured":"Dennis S.J., O\u2019Kennedy M.M., Rutkowska D., Tsekoa T., Lourens C.W., Hitzeroth I.I., Meyers A.E. and Rybicki E.P. (2018). Safety and immunogenicity of plant-produced African horse sickness virus-like particles in horses. BMC https:\/\/veterinaryresearch.biomedcentral.com\/articles\/https:\/\/doi.org\/10.1186\/s13567-018-0600-4.","DOI":"10.1186\/s13567-018-0600-4"},{"key":"2540_CR29","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1016\/j.vaccine.2014.04.036","volume":"32","author":"B Alberca","year":"2014","unstructured":"Alberca B, Bachanek-Bankowska K, Cabana M, Calvo-Pinilla E, Viaplana E, Frost L, Gubbins S, Urniza A, Mertens P, Castillo-Olivares J. Vaccination of horses with a recombinant modified vaccinia Ankara virus (MVA) expressing African horse sickness (AHS) virus major capsid protein VP2 provides complete clinical protection against challenge. Vaccine. 2014;32:3670\u20134.","journal-title":"Vaccine"},{"key":"2540_CR30","doi-asserted-by":"publisher","first-page":"4434","DOI":"10.1016\/j.vaccine.2009.05.044","volume":"27","author":"AJ Guthrie","year":"2009","unstructured":"Guthrie AJ, Quan M, Lourens CW, Audonnet JC, Minke JM, Yao J, He L, Nordgren R, Gardner IA, Maclachlan NJ. Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus. Vaccine. 2009;27:4434\u20138.","journal-title":"Vaccine"},{"issue":"2020","key":"2540_CR31","doi-asserted-by":"publisher","first-page":"102967","DOI":"10.1016\/j.jevs.2020.102967","volume":"88","author":"U Wernery","year":"2020","unstructured":"Wernery U, Joseph S, Raghavan R, Dyer B, Spendrup S. African horse sickness fever in vaccinated horses: short communication. J Equine Vet Sci. 2020;88(2020):102967.","journal-title":"J Equine Vet Sci"},{"key":"2540_CR32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0042-6822(62)90172-1","volume":"18","author":"J Wk","year":"1962","unstructured":"Wk J. The purification of four strains of poxvirus. Virology. 1962;18:9\u201318.","journal-title":"Virology."},{"issue":"2","key":"2540_CR33","first-page":"47","volume":"30","author":"H Mirchamsy","year":"1966","unstructured":"Mirchamsy H, Taslimi H. The formation of plaques by African horse sickness viruses and factors affecting plaque size. Can J Comp Med Vet Sci. 1966;30(2):47\u201351.","journal-title":"Can J Comp Med Vet Sci"},{"key":"2540_CR34","unstructured":"OIE, Manual of Diagnostic Test and Vaccines for Terrestrial Animals. Test for sterility and freedom from contamination of biological materials intented for veterinary use, 8th ed., OIE, 109\u2013122."},{"key":"2540_CR35","volume-title":"Immunogenicity of two adjuvant formulations of an inactivated African horse sickness vaccine in guinea-pigs and target animals","author":"GF Ronchi","year":"2012","unstructured":"Ronchi GF, Ulisse S, Rossi E, Franchi P, Armillotta G, Capista S, Peccio A, Di Ventura M, Pini A. Immunogenicity of two adjuvant formulations of an inactivated African horse sickness vaccine in guinea-pigs and target animals; 2012."},{"issue":"1","key":"2540_CR36","first-page":"81","volume":"14","author":"H Mirchamsy","year":"1968","unstructured":"Mirchamsy H, Taslimi H. Inactivated African horse sickness virus cell culture vaccine. Immunology. 1968;14(1):81\u20138.","journal-title":"Immunology."},{"issue":"5","key":"2540_CR37","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/j.1439-0450.1973.tb01136.x","volume":"20","author":"HG Bahnemann","year":"1972","unstructured":"Bahnemann HG. The inactivation of foot-and-mouth disease virus by ethylenimine and propylenimine. Zentralbl Veterinarmed B. 1972;20(5):356\u201360.","journal-title":"Zentralbl Veterinarmed B"},{"issue":"4","key":"2540_CR38","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/0264-410X(90)90083-X","volume":"8","author":"HG Bahnemann","year":"1990","unstructured":"Bahnemann HG. Inactivation of viral antigens for vaccine preparation with particular reference to the application of binary ethylenimine. Vaccine. 1990;8(4):299\u2013303.","journal-title":"Vaccine"},{"key":"2540_CR39","first-page":"37","volume":"54","author":"European Commission","year":"2002","unstructured":"European Commission. Commission decision of 21 February 2002 amending annex D to council directors 90\/426\/EEC with regard to diagnostic tests for African horse sickness. Off J Eur Communities. 2002;54:37\u201342.","journal-title":"Off J Eur Communities"},{"key":"2540_CR40","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1017\/S0950268800059483","volume":"104","author":"C Hamblin","year":"1990","unstructured":"Hamblin C, Graham SD, Anderson EC, Crowther JR. A competitive ELISA for the detection of group-specific antibodies to African horse sickness virus. Epidemiol Infect. 1990;104:303\u201312.","journal-title":"Epidemiol Infect"},{"issue":"1","key":"2540_CR41","first-page":"89","volume":"49","author":"R Lelli","year":"2013","unstructured":"Lelli R, Molini U, Ronchi GF, Rossi E, Franchi P, Ulisse S, Armilotta G, Capista S, Khaiseb S, Di Ventura M, Pini A. Inactivated and ajuvanated vaccine for the control of the African horse sickness virus serotype 9 infection: evaluation of efficacy in horses and Guinea-pig model. Vet Ital. 2013;49(1):89\u201398.","journal-title":"Vet Ital"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-020-02540-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12917-020-02540-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-020-02540-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T20:16:45Z","timestamp":1630441005000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-020-02540-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2540"],"URL":"https:\/\/doi.org\/10.1186\/s12917-020-02540-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.18248\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.18248\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.18248\/v3","asserted-by":"object"}]},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,1]]},"assertion":[{"value":"1 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An Ethic Commission comprising 4 veterinarians of the Central Veterinary Research Laboratory (CVRL) and a government veterinarian from the Ministry of Climate Change and Environment (MOCCAE), United Arab Emirates, follow the Ministerial Decree No. 384 of the year 2008 on the executive by-law of the Federal Law No. 16 of the year 2007 concerning Animal Welfare. The Welfare of all experimental animals and treatment of them conducted by the Central Veterinary Research Laboratory are reviewed and approved by the Animal Ethic Committee of Central Veterinary Research Laboratory and Ministry of Climate Change and Environment of the United Arab Emirates (Permit Number: 550353). The horses used in this experiment belong to His Highness Sheikh Mohammed bin Rashid Al Maktoum Vice President and Prime Minister of the UAE and ruler of Dubai, founder of Central Veterinary Research Laboratory who verbally approved this trial.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"322"}}